In Schizosaccharomyces pombe, this uncharacterized glycosyltransferase, C4F11.04c (SPCC4F11.04c), along with imt1 and imt3, is essential for mannosyl phosphorylinositol ceramide (MIPC) synthesis. Specifically, it catalyzes the addition of mannose to phosphorylinositol ceramide (IPC). MIPC plays a crucial role in cell morphology, cell-surface ergosterol distribution, plasma-membrane transporter localization, and lipid-raft-mediated endocytosis of plasma membrane proteins to the vacuole.
KEGG: spo:SPCC4F11.04c
STRING: 4896.SPCC4F11.04c.1
While the three-dimensional structure of SPCC4F11.04c has not been experimentally determined, bioinformatic analysis suggests it likely adopts a GT-A fold typical of many glycosyltransferases. These enzymes typically contain a Rossmann-like nucleotide-binding domain and often possess a DxD motif or similar catalytic residues that coordinate divalent cations (commonly Mn²⁺) essential for the sugar transfer reaction.
A methodological approach to predict structural features would include:
Multiple sequence alignment with characterized glycosyltransferases
Homology modeling based on structurally characterized glycosyltransferases
Secondary structure prediction to identify potential transmembrane regions
Active site prediction through conservation analysis and structural modeling
Validation of predictions through targeted mutagenesis studies
The recombinant expression and purification of SPCC4F11.04c can be achieved through the following methodological approach:
Expression system: The full-length protein (amino acids 1-345) can be expressed in E. coli as a His-tagged fusion protein.
Purification protocol:
Affinity chromatography using Ni-NTA resin for His-tagged protein
Size exclusion chromatography for further purification if needed
Final product can be obtained as a lyophilized powder
Storage conditions:
Quality control for recombinant SPCC4F11.04c should include:
SDS-PAGE analysis to confirm purity (>90% purity is typically achievable)
Western blot analysis using anti-His antibodies to confirm identity
Mass spectrometry to verify the intact mass and sequence
Circular dichroism to assess proper folding
Dynamic light scattering to evaluate homogeneity and aggregation state
Activity assays to confirm functional integrity (if the enzymatic function is known)
Verification of SPCC4F11.04c's glycosyltransferase function requires a multi-faceted approach:
Bioinformatic analysis:
Mutagenesis studies:
Enzymatic assays:
In vivo functional complementation:
Generate SPCC4F11.04c deletion strains in S. pombe
Test for phenotypic effects and complementation with wild-type and mutant alleles
The combined results from these approaches would provide strong evidence for the enzymatic function and specificity of SPCC4F11.04c.
Based on its annotation as "Inositol phosphoceramide mannosyltransferase 2," SPCC4F11.04c likely:
Uses GDP-mannose as the sugar donor, which is one of the nine sugar nucleotide donors used by mammalian glycosyltransferases and is conserved in fungi
Transfers mannose to inositol phosphoceramide (IPC) acceptors, which are important sphingolipid components in fungal membranes
May function as either a "retaining" or "inverting" glycosyltransferase, depending on whether the stereochemistry of the glycosidic bond is maintained or inverted during transfer
Potentially requires divalent cations (commonly Mn²⁺) as cofactors for catalysis
A systematic approach to substrate identification would involve testing activity with various sugar donors and acceptors, followed by product characterization using techniques such as mass spectrometry or NMR.
Gene deletion study:
Create a precise deletion of SPCC4F11.04c using PCR-based gene targeting
Analyze the viability of deletion mutants under various growth conditions
Context from genome-wide studies:
Conditional expression systems:
If conventional deletion is lethal, use repressible promoters to control expression
Monitor phenotypic consequences of protein depletion
Functional domain analysis:
Create partial deletions or point mutations that affect specific protein domains
Determine which domains are essential for function and viability
If SPCC4F11.04c functions in glycolipid biosynthesis or cell wall maintenance, its deletion might affect cell integrity, morphology, or stress resistance, even if not directly essential for viability.
Structural characterization of SPCC4F11.04c would benefit from these methodological approaches:
X-ray crystallography workflow:
Optimize protein construct design (remove flexible regions if necessary)
Screen crystallization conditions systematically
Co-crystallize with donor analogs and/or acceptor substrates
Solve structure using molecular replacement with related glycosyltransferases
Cryo-electron microscopy:
Particularly useful if the protein forms larger complexes or is membrane-associated
Can potentially capture different conformational states during catalysis
NMR spectroscopy:
For studying protein dynamics and substrate interactions
Particularly valuable for identifying flexible regions important for catalysis
Integrative modeling:
Combine low-resolution experimental data with computational predictions
Use homology modeling based on related glycosyltransferases with known structures
Validate models through targeted mutagenesis and functional assays
Molecular dynamics simulations:
Explore conformational flexibility and substrate binding mechanisms
Investigate the role of metal ions in catalysis
These approaches would provide insights into the structural basis of substrate recognition and catalytic mechanism of SPCC4F11.04c.
The active site of SPCC4F11.04c can be systematically identified and characterized through:
Multiple sequence alignment:
Three-dimensional modeling:
Site-directed mutagenesis:
Substrate docking and molecular dynamics:
Predict binding modes of donor and acceptor substrates
Simulate enzyme-substrate interactions
Biochemical validation:
Compare catalytic parameters of wild-type and mutant proteins
Analyze effects of metal ions and pH on enzyme activity
This integrated approach would reveal both the identity of catalytic residues and the structural basis for substrate specificity, providing a foundation for more detailed mechanistic studies.
The regulation and localization of SPCC4F11.04c could be investigated through:
Localization studies:
Post-translational modifications:
Phosphorylation sites could be identified by mass spectrometry
Effects of phosphorylation on activity could be tested with phosphomimetic mutations
Glycosylation of the enzyme itself might affect folding or stability
Transcriptional regulation:
RNA-seq analysis under various conditions to identify regulatory cues
Promoter analysis to identify transcription factor binding sites
Protein-protein interactions:
Identify interaction partners through co-immunoprecipitation or yeast two-hybrid
Assess if activity is regulated through complex formation
Environmental responsiveness:
Test enzyme activity under various stress conditions
Analyze expression patterns during different growth phases
Understanding these regulatory aspects would provide insights into how SPCC4F11.04c activity is coordinated with broader cellular processes.
A methodological approach to evolutionary analysis of SPCC4F11.04c would include:
Homology identification:
BLAST searches against fungal genomes to identify orthologs
Assessment of conservation versus divergence patterns
Phylogenetic analysis:
Construction of phylogenetic trees to trace evolutionary history
Correlation with known glycosylation pathways across species
Conservation mapping:
Identify highly conserved regions likely critical for function
Map conservation onto structural models to predict functional sites
Comparative genomic context:
Analyze gene neighborhoods across species
Identify co-evolved genes that might function in the same pathway
Functional divergence:
Determining the catalytic mechanism would involve:
Stereochemical analysis:
Kinetic analysis:
Steady-state kinetics with varying substrate concentrations
Pre-steady-state kinetics to identify rate-limiting steps
pH and temperature dependence studies
Isotope effects:
Measure kinetic isotope effects using labeled substrates
Distinguish between concerted and stepwise mechanisms
Mechanistic inhibition studies:
Design and test transition state analogs
Analyze patterns of inhibition
Metal ion requirements:
Test activity with various divalent cations (Mn²⁺, Mg²⁺, etc.)
Determine if metal coordinates substrate, enzyme, or both
The combined results would elucidate whether SPCC4F11.04c follows a direct displacement (inverting) or double displacement (retaining) mechanism, providing fundamental insights into its catalytic strategy.
If SPCC4F11.04c functions as an inositol phosphoceramide mannosyltransferase, it likely contributes to:
Glycosphingolipid biosynthesis:
Generation of mannosylinositol phosphoceramides (MIPCs)
These complex lipids are important components of fungal membranes
Membrane microdomain organization:
Glycosphingolipids contribute to lipid raft formation
These microdomains organize membrane proteins and signaling complexes
Cell wall-membrane interface:
Glycolipids may connect membrane components to cell wall polysaccharides
This interface is critical for cell integrity and stress response
A comprehensive investigation would include:
Analysis of membrane lipid composition in wild-type versus mutant strains
Cell wall integrity testing using agents like Calcofluor White or Congo Red
Stress response analysis under various conditions
Electron microscopy to examine cell wall ultrastructure
Lipidomic profiling to identify specific substrates and products
The potential of SPCC4F11.04c as an antifungal target could be evaluated through:
Essentiality assessment:
Determine if the gene is essential or if its deletion causes significant fitness defects
Evaluate growth under various stress conditions relevant to host environments
Conservation analysis:
Compare conservation between pathogenic fungi and humans
Identify structural or functional differences that could be exploited for selectivity
Inhibitor screening:
Develop high-throughput assays for enzyme activity
Screen chemical libraries for selective inhibitors
Structure-based drug design:
Use structural information to design specific inhibitors
Optimize lead compounds for potency and selectivity
Validation in model systems:
Test promising inhibitors in fungal culture
Evaluate toxicity in mammalian cell lines
Assess efficacy in animal models of fungal infection
If SPCC4F11.04c is involved in fungal-specific glycolipid synthesis with no close homologs in mammals, it could represent an attractive target for selective antifungal development.
A comprehensive strategy for SPCC4F11.04c characterization would integrate:
Molecular and structural studies:
Biochemical characterization:
Development of quantitative activity assays
Determination of substrate specificity and kinetic parameters
Analysis of metal ion and pH dependence
Cellular studies:
Generation and phenotypic characterization of deletion mutants
Localization studies using fluorescent protein fusions
Lipidomic analysis of wild-type versus mutant strains
Systems biology approaches:
Transcriptomic profiling under various conditions
Identification of genetic interactions through synthetic genetic arrays
Metabolic flux analysis of relevant biosynthetic pathways
Integration with glycobiology knowledge:
Comparison with characterized glycosyltransferases from model organisms
Placement within known glycosylation pathways
This integrated approach would provide a comprehensive understanding of SPCC4F11.04c function from molecular mechanism to cellular significance and evolutionary context.